Depletion of Adipose Stroma-Like Cancer-Associated Fibroblasts Potentiates Pancreatic Cancer Immunotherapy
Author Information
Author(s): Rupert Joseph, Daquinag Alexes, Yu Yongmei, Dai Yulin, Zhao Zhongming, Kolonin Mikhail G.
Primary Institution: The Brown Foundation Institute of Molecular Medicine for the Prevention of Disease, McGovern Medical School, Houston, Texas.
Hypothesis
The study investigates the roles of cancer-associated fibroblasts (CAFs) expressing specific markers in pancreatic cancer progression and therapy resistance.
Conclusion
Depletion of ASC-like CAFs enhances the effectiveness of immune checkpoint blockade therapy in pancreatic cancer.
Supporting Evidence
- Depletion of Pdgfrb+ cells suppressed primary pancreatic tumor growth.
- A peptide D-CAN reduced pancreatic tumor growth and extracellular matrix deposition.
- Depletion of ASC-like CAFs led to higher infiltration of cytotoxic T-lymphocytes and B-lymphocytes.
- Combination treatment with D-CAN and anti-PDL1 antibody showed a stronger suppressive effect on tumor growth.
Takeaway
This study shows that certain cells in tumors can help cancer grow, and removing them can make treatments work better.
Methodology
The study used mouse models of pancreatic cancer to analyze the effects of depleting specific CAF populations on tumor growth and metastasis.
Limitations
The study primarily used mouse models, which may not fully replicate human disease.
Participant Demographics
Mice were used in the study, including both male and female subjects.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website